User:Odal46/sandbox

= Alimetry =

Alimetry Limited is a company which designs, manufactures, and markets wearable medical devices to aid in the diagnosis of gastric dysfunction.

History
Alimetry was founded in 2019 in New Zealand by Professor Greg O’Grady and Dr Armen Gharibans. The company is a spin-out of the University of Auckland’s Bioengineering Institute.

Alimetry raised its first round of capital in December 2020. In March 2022, Alimetry announced a Series A raise of NZD $16.3 million. The round was led by investment fund Movac, alongside existing investors UniServices, IP Group and Matū Karihi. K1W1 also participated in the round.

Alimetry's US-based subsidiary, called Alimetry Inc., was founded in 2022. The subsidiary is based in Minneapolis, MN.

Gastric Alimetry
Alimetry’s first product is called Gastric Alimetry, and it is a non-invasive, wearable device which records electrophysiological data from the stomach alongside patient-reported symptoms such as nausea, vomiting, abdominal pain, and bloating.

The output of the test is a report that clinicians can use to assist with the diagnosis of chronic nausea and vomiting disorders such as Gastroparesis.

Gastric Alimetry received FDA approval and UKCA marking in 2022. The device is currently available for use in the USA, UK, and New Zealand.